` KAEF (Kimia Farma Tbk PT) vs Jakarta Composite Index Comparison - Alpha Spread

KAEF
vs
Jakarta Composite Index

Over the past 12 months, KAEF has underperformed Jakarta Composite Index, delivering a return of -42% compared to the Jakarta Composite Index's 7% drop.

Stocks Performance
KAEF vs Jakarta Composite Index

Loading

Performance Gap
KAEF vs Jakarta Composite Index

Loading
KAEF
Jakarta Composite Index
Difference

Performance By Year
KAEF vs Jakarta Composite Index

Loading
KAEF
Jakarta Composite Index
Add Stock

Competitors Performance
Kimia Farma Tbk PT vs Peers

Jakarta Composite Index
KAEF
LLY
JNJ
NOVO B
ROG
Add Stock

Kimia Farma Tbk PT
Glance View

Market Cap
2.4T IDR
Industry
Pharmaceuticals

PT Kimia Farma Tbk engages in the production and distribution of healthcare products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 11,668 full-time employees. The company went IPO on 2001-07-04. The firm produces medical devices and chemical materials. The firm is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.

KAEF Intrinsic Value
1 035.25 IDR
Undervaluation 58%
Intrinsic Value
Price
Back to Top